Literature DB >> 3356785

Risk factors for candidemia in cancer patients: a case-control study.

A Karabinis1, C Hill, B Leclercq, C Tancrède, D Baume, A Andremont.   

Abstract

Risk factors for candidemia were analyzed in a case-control study of 30 cancer patients with candidemia and 58 controls. In a univariate analysis, previous surgery, neutropenia, central catheterization, chemotherapy, specific antibiotic treatments, and peripheral cultures positive for Candida spp. were associated with a significantly increased risk of candidemia. In a multivariate logistic model, the significant risk factors for candidemia were positive peripheral cultures for Candida spp. (P = 0.02), central catheterization (P = 0.03), and neutropenia (P = 0.05). These results should help to identify cancer patients with a high risk of candidemia, who should be given early systemic antifungal therapy.

Entities:  

Mesh:

Year:  1988        PMID: 3356785      PMCID: PMC266307          DOI: 10.1128/jcm.26.3.429-432.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Blood cultures: issues and controversies.

Authors:  J A Washington; D M Ilstrup
Journal:  Rev Infect Dis       Date:  1986 Sep-Oct

2.  Serial enzyme-linked immunosorbent assays for antibody to Candida antigens during induction chemotherapy for acute leukemia.

Authors:  R A Greenfield; M J Bussey; J L Stephens; J M Jones
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

3.  Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.

Authors:  P A Pizzo; K J Robichaud; F A Gill; F G Witebsky
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

4.  A semiquantitative culture method for identifying intravenous-catheter-related infection.

Authors:  D G Maki; C E Weise; H W Sarafin
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

Review 5.  Current trends in immunodiagnosis of candidiasis and aspergillosis.

Authors:  L de Repentigny; E Reiss
Journal:  Rev Infect Dis       Date:  1984 May-Jun

6.  The value of fungal surveillance cultures as predictors of systemic fungal infections.

Authors:  G R Sandford; W G Merz; J R Wingard; P Charache; R Saral
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

7.  Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia.

Authors:  R S Schwartz; F R Mackintosh; S L Schrier; P L Greenberg
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

8.  Candidiasis in cancer patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

9.  Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality.

Authors:  F Meunier-Carpentier; T E Kiehn; D Armstrong
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

10.  Fungal infections in patients with acute leukemia.

Authors:  M W DeGregorio; W M Lee; C A Linker; R A Jacobs; C A Ries
Journal:  Am J Med       Date:  1982-10       Impact factor: 4.965

View more
  46 in total

1.  Experience with invasive Candida infections.

Authors:  H Girishkumar; A M Yousuf; J Chivate; E Geisler
Journal:  Postgrad Med J       Date:  1999-03       Impact factor: 2.401

Review 2.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 3.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

4.  Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.

Authors:  J Pemán; E Cantón; M Gobernado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

5.  Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients.

Authors:  D D'Antonio; A Mazzoni; A Iacone; B Violante; M A Capuani; F Schioppa; F Romano
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

6.  A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies.

Authors:  D D'Antonio; B Violante; A Mazzoni; T Bonfini; M A Capuani; F D'Aloia; A Iacone; F Schioppa; F Romano
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

7.  Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: development and evaluation of a simple, standard protocol.

Authors:  Anna F Lau; Masrura Kabir; Sharon C-A Chen; E Geoffrey Playford; Deborah J Marriott; Michael Jones; Jeffrey Lipman; Emma McBryde; Thomas Gottlieb; Winston Cheung; Ian Seppelt; Jonathan Iredell; Tania C Sorrell
Journal:  J Clin Microbiol       Date:  2015-02-11       Impact factor: 5.948

8.  Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.

Authors:  Y F Berrouane; L A Herwaldt; M A Pfaller
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis.

Authors:  M E Bougnoux; C Hill; D Moissenet; M Feuilhade de Chauvin; M Bonnay; I Vicens-Sprauel; F Pietri; M McNeil; L Kaufman; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

10.  Unexpected candidemia complicating ureteroscopy and urinary stenting.

Authors:  M Gross; H Winkler; S Pitlik; M Weinberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.